Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they will publish the evidence behind their decision to ban puberty blocker medication from all providers; and what meetings the Secretary of State for Health and Social Care has had with the parents of trans children or teenagers, their representatives or organisations representing their concerns.

On 11 December 2024, the Government published its response to the consultation on whether to introduce indefinite restrictions to prevent new patients aged under 18 years old from being supplied with puberty blockers for the purposes of gender incongruence and/or gender dysphoria, under the care of private or non-United Kingdom prescribers. This response included recommendations from a report by an expert clinical committee, the Commission on Human Medicines. This decision has been further informed by the evidence gathered by Baroness Cass as part of her independent review of gender identity services for children and young people, The Cass Review, which is publicly available.

The Secretary of State for Health and Social Care has held constructive, open, and honest roundtable discussions, including with children and young people, and their parents, with lived experience of gender dysphoria and incongruence. The Government remains committed to listening to the LGBT+ community.